MedTrace Logo

Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

NCT04064619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-08-22

No results posted yet for this study

Summary

Our study included 60 patients with idiopathic OAB and treated with solifenacin 5mg twice daily for one month. After improvement of their condition, we divided the responders into 2 groups, group I stopped the drug suddenly, while group II underwent gradual weaning of the drug.

Conditions

  • Voiding Disorders

Interventions

DRUG

Solifenacin Succinate 5 MG

gradual weaning of drug vs. stopping

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Ahmed Abdelbary, MD · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-08-02
Completion
2019-08-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04064619 on ClinicalTrials.gov